In this context the importance of γδ T cells as an early source of IFN-γ in the treatment of cancers has been reported [24,25,26], and IFN-γ is considered a central cytokine in anti-tumor immune responses by γδ T cells [10]. The gene discussed is IFNG; the disease is neoplasm.